Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial

Hillmen, P (author)

Eichhorst, B (author)

Brown, JR (author)

show more...

Lamanna, N (author)

O'Brien, SM (author)

Tam, CS (author)

Qiu, LG (author)

Kazmierczak, M (author)

Zhou, KS (author)

Simkovic, M (author)

Mayer, J (author)

Gillespie-Twardy, A (author)

Shadman, M (author)

Ferrajoli, A (author)

Ganly, PS (author)

Weinkove, R (author)

Grosicki, S (author)

Mital, A (author)

Robak, T (author)

Osterborg, A (author)

Karolinska Institutet

Yimer, HA (author)

Salmi, T (author)

Ji, M (author)

Yecies, J (author)

Idoine, A (author)

Wu, K (author)

Huang, JE (author)

Jurczak, W (author)

show less...

 (creator_code:org_t)

2023

2023

English.

In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. - 1527-7755. ; 41:5, s. 1035-

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)